An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.
暂无分享,去创建一个
[1] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[2] S Greenland,et al. Bias in the one-step method for pooling study results. , 1990, Statistics in medicine.
[3] R F Galbraith,et al. A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.
[4] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[5] D L Demets,et al. Methods for combining randomized clinical trials: strengths and limitations. , 1987, Statistics in medicine.
[6] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[7] J. Ockene. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1986, The American journal of cardiology.
[8] J. Huttunen,et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. , 1985, JAMA.
[9] I. Holme,et al. The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. , 1985, Preventive medicine.
[10] The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.
[11] M. Wilmet. Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results. , 1983, European heart journal.
[12] I. Holme,et al. EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.
[13] I. Hjermann,et al. EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE , 1981 .
[14] Jeremy N. Morris,et al. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. , 1980 .
[15] W. Martin,et al. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. , 1978, Journal of chronic diseases.
[16] C. Mcgilchrist,et al. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. , 1978, Advances in experimental medicine and biology.
[17] G. Rosenhamer,et al. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. , 1977, Atherosclerosis.
[18] J. Stamler. Clofibrate and niacin in coronary heart disease. , 1975, JAMA.
[19] E. Hutchinson,et al. Controlled trial of clofibrate in cerebral vascular disease. , 1972, Atherosclerosis.
[20] Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate , 1971 .
[21] Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGION* , 1971, British medical journal.
[22] U. Tomiyasu,et al. A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis , 1969 .
[23] J. N. Morris. Controlled trial of soyabean oil in myocardial infarction. , 1968 .
[24] P. Allhoff,et al. Controlled trial of soya-bean oil in myocardial infarction. , 1968, Lancet.
[25] W. B. Thomson,et al. Corn Oil in Treatment of Ischaemic Heart Disease , 1965, British medical journal.
[26] Aresearchcommittee. Low-fat diet in myocardial infarction: A controlled trial. , 1965, Lancet.